Pharmaceutically active compounds and methods of use

Details Pharmaceutically active compounds and methods of use Pharmaceutically active compounds and methods of use

2006-05-09

2006-05-09

O'Sullivan, Peter (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S618000, C514S622000, C514S623000, C514S311000, C514S314000, C514S355000, C514S414000, C514S415000, C514S448000, C514S471000, C564S161000, C564S162000, C564S170000, C564S174000, C564S176000, C564S177000, C564S179000, C564S182000, C564S183000, C564S184000, C564S185000, C546S165000, C546S277400, C546S280400, C546S283400, C546S332000, C548S454000, C548S455000, C548S465000, C548S491000, C549S072000, C549S487000

Reexamination Certificate

active

07041702

ABSTRACT:
The present invention relates to pharmaceutically acceptable compounds, including acylguanidine compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for the treatment or prophylaxis of neurological injury and neurodegenerative disorders.

REFERENCES:
patent: 3972872 (1976-08-01), Hamanaka
patent: 4156734 (1979-05-01), Stone
patent: 4544670 (1985-10-01), Studt et al.
patent: 5741661 (1998-04-01), Goldin et al.
patent: 5955507 (1999-09-01), Durant et al.
patent: 6013675 (2000-01-01), Durant et al.
patent: 6025355 (2000-02-01), Reddy et al.
patent: 24 33 625 (1975-01-01), None
patent: 25 31 343 (1977-02-01), None
patent: 25 45 647 (1977-04-01), None
patent: 27 33 440 (1978-02-01), None
patent: 28 02 757 (1979-07-01), None
patent: 0 062 844 (1982-10-01), None
patent: 2.222.375 (1974-10-01), None
patent: WO 94/27591 (1994-12-01), None
patent: WO98/06401 (1998-02-01), None
Okajima et al. Chem. Abst. 115:29165, 1991.
Fukada et al., Chem Abst. 105:152653, 1986.
Augustin et al., Chem. Abst. 100:138782, 1984.
Gund et al. Chem. Abst. 77:163827, 1972.
Malyuga et al. Chem. Abst. 74:136938, 1971.
Neidlein et al., Chem. Abst. 67:100033, 1967.
Buscemi et al., “Heterocyclic Photorearrangements. Photochemical Behavior of Some 3,4-Disubstituted 1,2,4-Oxadiozoles in Methanol at 254 nm”,Journal of Hetrocyclic Chemistry,May-Jun. 1988, vol. 25, No. 3, pp. 931-935.
Buschauer, V.A., “Synthese und pharmakologische Wirkung von Arylmethylthioethylguanidinen”,Arzneimittel Forschung,Sep. 1987, vol. 37, No. 9, pp. 1008-1012.
Gund et al., “A Novel Reaction of Guanidine with Benzaldehydes”,Tetrahedron Letters,Sep. 1972, No. 38, pp. 3983-3986.
Mitsunobu et al., “Preparation and Reactions of N-Benzoyl- and N- Ethoxycarbonylcarbodiimides”,Bulletin of the Chemical Society of Japan,Dec. 1972, vol. 45, No. 12, pp. 3607-3611.
Nagasawa et al., “Alkylation of Thioureas and Related Compounds by Use of Alcohols, Diethyl Azodibarboxylate, and Triphenylphosphine”,The Chemical Society of Japan,Jul. 1981, vol. 54, No. 7, pp. 2223-2224.
Nakayama et al., “Synthesis and Structure-Activity Study of Protease Inhibitors”,Chemical Pharmaceutical Bulletin,Jan. 1993, vol. 41, No. 1, pp. 117-125.
Okajima et al., “Synthesis and Reaction of 2-Imino-1, 3-thiazetidines and 2-Imino-1, 3-dithietanes”,Journal of Heterocyclic Chemistry,Jan. 1991, vol. 28, No. 1, pp. 177-185.
Schneller et al., “Synthesis of proximal-Benzoguanine and a Simplified Synthesis of proximal-Benzohypoxanthine”,Journal of Organic Chemistry,1986, vol. 51, No. 21, pp. 4067-4070.
Trumm et al., “Tetrahydroisochinoline als Bausteine von H2-Antagonisten”,Arzneimittel Gorschung,Aug. 1986, vol. 36, No. 8, pp. 1169-1174.
Yamazaki et al., “Synthesis of Guanosine and Its Derivatives from 5-Amino-1-beta-D-ribofuranosyl-l-imidazolecarboxamide”,Journal of Organic Chemistry,Jun. 1967, vol. 32, No. 6, pp. 1825-1828.

Affiliated with

Also associated with

Rating

Pharmaceutically active compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutically active compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active compounds and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3528354